<DOC>
	<DOCNO>NCT00001481</DOCNO>
	<brief_summary>Determine whether postpartum depression trigger abrupt withdrawal estrogen progesterone . The appearance mood behavioral symptom pregnancy postpartum period extensively report . While much speculation possible biologically base etiology postpartum disorder ( PPD ) , none ever confirm . Preliminary result two related study ( protocols 90-M-0088 , 92-M-0174 ) provide evidence woman menstrual cycle relate mood disorder , control , experience mood disturbance exogenous replacement physiologic level gonadal steroid . The present protocol design create `` scaled-down '' hormonal milieu pregnancy puerperium order determine whether woman previous episode postpartum major effective episode experience differential mood behavioral effect compare control determine whether abrupt withdrawal gonadal steroid prolong exposure gonadal steroid associate mood symptom . Supraphysiologic plasma level gonadal steroid establish , maintain , rapidly reduce , simulate hormonal event occur pregnancy parturition . This accomplish administer estradiol progesterone woman pretreated gonadotropin release hormone ( GnRH ) agonist ( Lupron ) . After eight week , administration gonadal steroid stop one group patient control , sudden decline plasma hormone level precipitate . Another group maintain supraphysiologic level estrogen progesterone additional month . Outcome measure include mood , behavioral hormonal parameter well response o-CRH ( separate protocol do collaboration NICHD ) .</brief_summary>
	<brief_title>The Role Hormones Postpartum Mood Disorders</brief_title>
	<detailed_description>The appearance mood behavioral symptom pregnancy postpartum period extensively report . While much speculation possible biologically base etiology postpartum disorder ( PPD ) , none ever confirm . Preliminary result two related study ( protocols 90-M-0088 , 92-M-0174 ) provide evidence woman menstrual cycle relate mood disorder , control , experience mood disturbance exogenous replacement physiologic level gonadal steroid . The present protocol design create scaled-down hormonal milieu pregnancy puerperium order determine whether woman previous episode postpartum major affective episode experience differential mood behavioral effect compare control determine whether abrupt withdrawal gonadal steroid prolong exposure gonadal steroid associate mood symptom . Supraphysiologic plasma level gonadal steroid establish , maintain , rapidly reduce , simulate hormonal event occur pregnancy parturition . This accomplish administer estradiol progesterone woman pretreated gonadotropin release hormone ( GnRH ) agonist ( Lupron ) . After eight week , administration gonadal steroid stop one group patient control , sudden decline plasma hormone level precipitate . Another group maintain supraphysiologic level estradiol progesterone additional month . Outcome measure include mood , behavioral , hormonal parameter well response o-CRH .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Mood Disorders</mesh_term>
	<mesh_term>Depression , Postpartum</mesh_term>
	<criteria>INCLUSION CRITERIA : A . Group 1 : Women history postpartum depression : 1 . A history DSMIV major depression hypomanic/manic episode occur within three month childbirth ( determined SCID interview ) ; 2. well minimum one year ; 3. regular menstrual cycle least three month ; 4. age 1850 ; 5. pregnant , lactate good medical health ; 6. medication free ( include birth control pill ) ; 7. history puerperal suicide attempt psychotic episode require hospitalization . Group 2 : Women history Major Depressive Disorder 1 . A history DSMIV major depression episode ( ) occur outside pregnancy within three month postpartum ; 2. well minimum one year ; 3. regular menstrual cycle least three month ; 4. age 1850 ; 5. pregnant , lactate good medical health ; 6. medication free ( include birth control pill ) ; 7. history suicide attempt psychotic episode require hospitalization . Group 3 ; Normal Controls 1 . Controls meet criterion specify except must past present Axis I diagnosis evidence menstrually related mood disorder . 2 . A structured clinical interview DSMIV ( SCID ) administer woman prior study entry . Any woman current axis I psychiatric diagnosis exclude participate protocol . EXCLUSION CRITERIA : Patients permit enter protocol important clinical laboratory abnormality include history following : endometriosis ; undiagnosed enlargement ovary ; liver disease ; breast cancer ; history blood clot legs lung ; undiagnosed vaginal bleeding ; porphyria ; diabetes mellitus ; malignant melanoma ; gallbladder pancreatic disease ; heart kidney disease ; cerebrovascular disease ( stroke ) ; cigarette smoking ; history suicide attempt psychotic episode require hospitalization ; recurrent migraine headache ; pregnancy ( patient warn become pregnant study advise employ barrier contraceptive method ; pregnancyrelated medical condition hyperemesis gravidarum , pretoxemia toxemia , deep vein thrombosis ( DVT ) bleed diathesis ; Any woman first degree relative ( immediate family ) premenopausal breast cancer breast cancer present breast woman multiple family member ( great three relative ) postmenopausal breast cancer also exclude participate protocol ; Any woman meeting Stages Reproductive Aging Workshop Criteria ( STRAW ) perimenopause exclude participation . Specifically , exclude woman elevate plasma FSH level ( great equal to14 IU/L ) menstrual cycle variability &gt; 7 day different normal cycle length . Subjects unable provide inform consent .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 25, 2016</verification_date>
	<keyword>Postpartum Disorders</keyword>
	<keyword>Depression</keyword>
	<keyword>Mood</keyword>
	<keyword>Postpartum Depression</keyword>
	<keyword>Hormones</keyword>
	<keyword>Pregnancy</keyword>
	<keyword>Estrogen</keyword>
	<keyword>Progesterone</keyword>
	<keyword>Gonadal Steroids</keyword>
	<keyword>GnRH Agonist</keyword>
	<keyword>Postpartum</keyword>
	<keyword>Mood Disorder</keyword>
</DOC>